EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A review of JAK and IL ‐23 inhibitors to treat vitiligo

Henry Lee iD, Timothy L Cowan iD, Benjamin S Daniel iD, Dédée F Murrell iD

Australasian Journal of Dermatology · 2023

DOI: 10.1111/ajd.14001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Australasian Journal of Dermatology, 2023. Verfasst von Henry Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Vitiligo, Dermatologic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is an autoimmune skin disorder resulting in the depigmentation of skin characterised by patches of varying sizes and shapes. A common disorder of pigmentation that affects 0.5%–2% of the global population. Despite its well‐understood autoimmune pathogenesis, the targets for effective cytokine intervention remain unclear. Current first‐line treatments include oral or topical corticosteroids, calcineurin inhibitors and phototherapy. These treatments are limited, have varying efficacies, and are associated with significant adverse events or can be time‐consuming. Therefore, biologics should be explored as a potential treatment for vitiligo. There are currently limited data for the use of JAK and IL‐23 inhibitors for vitiligo. A total of 25 studies were identified in the review. There is promising evidence regarding the use of JAK and IL‐23 inhibitors for the treatment of vitiligo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoDermatologic AgentsHumansPhototherapyCalcineurin InhibitorsInterleukin-23

Stichwörter der Autor:innen

Interleukin-23Janus kinase inhibitorsVitiligobiologicsmanagementtherapytreatment

Substanzen

Dermatologic AgentsCalcineurin InhibitorsInterleukin-23

Autor:innen und Institutionen

  • Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia.

ORCID-Profile: Henry Lee, Timothy L Cowan, Benjamin S Daniel, Dédée F Murrell

Zitieren

APA

Lee, H., Cowan, T. L., Daniel, B. S., & Murrell, D. F. (2023). A review of JAK and IL ‐23 inhibitors to treat vitiligo. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14001

Vancouver

Lee H, Cowan TL, Daniel BS, Murrell DF. A review of JAK and IL ‐23 inhibitors to treat vitiligo. Australasian Journal of Dermatology. 2023. doi:10.1111/ajd.14001

BibTeX
@article{Lee2023,
  author = {Lee, Henry and Cowan, Timothy L and Daniel, Benjamin S and Murrell, Dédée F},
  title = {A review of JAK and IL ‐23 inhibitors to treat vitiligo},
  journal = {Australasian Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ajd.14001}
}
Kostenlos starten →